Effects of cyclosporin A on progressive and regressive tumors induced by two cancer lines derived from a single colon carcinoma chemically induced in the rat

T ShimizuF Martin


The effects of cyclosporin-induced immunosuppression were assessed in a rat model of progressive and regressive colonic tumors. Two cloned cell variants, obtained from the same chemically induced colonic carcinoma, differ in their capacity to grow when injected into the syngeneic rat. PROb cells yield progressive tumors and often metastases; in contrast, REGb cells produce tumors which regress in 3 to 6 weeks. Cyclosporin A (CsA) administered daily, 20 mg/kg subcutaneously (s.c.) for 30 days after tumor cell inoculation, drastically enhanced the local growth of PROb tumors and increased the number of metastases. It increased the local growth and prevented the regression of REGb tumors which persisted even as long as 8 weeks after the termination of CsA administration and occasionally yielded metastases. CsA prevented the accumulation of inflammatory cells with the T lymphocyte phenotype at the periphery of both PROb and REGb tumors but did not alter the tumor infiltration by macrophages and NK cells. CsA did not modify the natural cytotoxicity of peripheral blood mononuclear cells against PROb and REGb target cells. These results suggest that CsA-induced suppression of T lymphocyte activity may enhance tumor progression and sup...Continue Reading


Jul 1, 1985·The Journal of Experimental Medicine·W A JefferiesA F Williams
Nov 15, 1987·International Journal of Cancer. Journal International Du Cancer·T ShimizuF Martin
Feb 1, 1985·Immunological Investigations·J SenguptaB H Tom
Aug 15, 1985·International Journal of Cancer. Journal International Du Cancer·A CaignardF Martin
Nov 15, 1983·International Journal of Cancer. Journal International Du Cancer·F MartinM Martin
Sep 1, 1984·The Journal of Surgical Research·F E JohnsonD R Herbold
Aug 1, 1980·European Journal of Immunology·R J BrideauA F Williams
Feb 1, 1981·Transplantation·M IntronaA Mantovani

❮ Previous
Next ❯


Jan 1, 1992·Toxicology·B Ryffel
Aug 15, 2002·Cancer Letters·Toshiyuki TanakaHidetoshi Yamanaka
Jan 5, 2002·Veterinary Surgery : VS·John D WooldridgeAndrew E Kyles
Mar 16, 2012·Cancer Biotherapy & Radiopharmaceuticals·Sophie E ErikssonJan Tennvall
Jun 30, 2004·Transplantation·Markus GubaEdward K Geissler
Feb 1, 1994·International Journal of Cancer. Journal International Du Cancer·A MénoretJ Le Pendu
Mar 28, 2006·The American Journal of Medicine·Ashok K MalaniDavid Debono
Jan 1, 1992·Drug and Chemical Toxicology·B RyffelG L Fisher
Oct 21, 1992·International Journal of Cancer. Journal International Du Cancer·H M BlottièreJ Le Pendu
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·B BonnotteF Martin
Jan 30, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A E CoghillM M Madeleine
Feb 6, 2019·Oncogene·Mengxiong WangBrian K Law

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.